1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Aprea Therapeutics Inc (APRE)

  7. Aprea Therapeutics Inc (APRE) Financials

APRE

Aprea Therapeutics Inc
4.60
-0.1502 (-3.16%)
Upgrade to Real-Time

Aprea Therapeutics Inc. (APRE) Fundamentals
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing cancer therapeutics that reactivate mutant p53 tumor suppressor protein. Its product candidate, APR-246, is a small molecule p53 reactivator that is in late-stage clinical development for hematologic malignancies, including myelodysplastic syndromes (MDS), and acute myeloid leukemia (AML).
SHARE INFORMATION
Market CapUS$ 17,986,167
Shares Outstanding3,731,570
Float3,179,918
Percent Float85.22%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per ShareUS$ 0.00
Latest Fiscal RevenueUS$ 0
Latest Fiscal EPSUS$ -34.80
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)US$ 0.00
Dividend (5 Years)US$ 0.00
Ex Dividend Date-
Dividend RateUS$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions67
Institutional Holdings Date2023-02-28
Institutional Bought Previous 3 Months114,913
Institutional Holdings Percent3.3%
Institutional Sold Previous 3 Months399,008
Insider Holdings Date2023-02-28
Insider Bought Previous 3 Months2,431,911
Insider Holdings Percent38.9
Insider Sold Previous 3 Months-
Insider Shares Owned1,450,074
TRADING INFO
52 Week HighUS$ 40.80
52 Week LowUS$ 4.80
52 Week High ChangeUS$ -86.76
21 Day Moving AverageUS$ 5.1505
21 Day Extended Moving AverageUS$ 5.5969
50 Day Moving AverageUS$ 7.6771
50 Day Extended Moving AverageUS$ 6.9281
200 Day Moving AverageUS$ 12.6157
200 Day Extended Moving AverageUS$ 15.979
10 Day Average Volume18,822
20 Day Average Volume21,882
30 Day Average Volume21,021
50 Day Average Volume18,393
Alpha0.412815
Beta2.7425
Standard Deviation3.202860
R20.002489
7 Day Price ChangeUS$ -0.40
7 Day Percent Change-7.66%
21 Day Price ChangeUS$ -0.38
21 Day Percent Change-7.31%
30 Day Price ChangeUS$ -1.49
30 Day Percent Change-23.61%
Month to Date Price ChangeUS$ -0.31
Month to Date Percent Change-6.04%
Quarter to Date Price ChangeUS$ -1.80
Quarter to Date Percent Change-27.19%
180 Day Price ChangeUS$ -10.47
180 Day Percent Change-68.48%
200 Day Price ChangeUS$ -10.78
200 Day Percent Change-69.1%
Year to Date Price ChangeUS$ -1.80
Year to Date Percent Change-27.19%

Aprea Therapeutics Inc. (APRE) Key Ratios

PROFITABILITY
EBIT Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
RevenueUS$ 0
Revenue Per ShareUS$ 0.00
Revenue (3 Years)US$ 0.00
Revenue (5 Years)US$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book0.70
Total Debt To Equity0.00
Int Coverage0.00
Current Ratio8.40
Leverage Ratio3.60
Quick Ratio8.30
Long Term Debt To Capital0.00
VALUATION MEASURES
PE Ratio0.00
Enterprise ValueUS$ -14,232,253
Price to Sales0.00
Price to Free Cash-0.90
PE High Last 5 Years0.00
Price To Book0.70
Price To Cash Flow0.00
PE Low Last 5 Years0.00
Price to Tangible Book0.70
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-245.51
Return on Equity-294.79
Return on Capital-293.45

Aprea Therapeutics Inc. (APRE) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorErnst & Young LLP
CEOOren Gilad
Emplyoees16
Last AuditUQ
CIK0001781983
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address535 Boylston Street
Boston, MA 2116
Websitehttps://www.aprea.com
Facsimile-
Telephone+1 617 463-9385
Emailchris.schade@aprea.com
Your Recent History
NASDAQ
APRE
Aprea Ther..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:au D:20230325 19:34:37